We hereby submit the Notice of 41st Annual General meeting of the members of the Company Scheduled to be held on Monday, the 21st day of September, 2026

CIN L33112MP1985PLC003039 RAAJ MEDISAFE INDIA LIMITED Regd. Office: 75/2 and 3, Industrial Area, Maksi Road, Ujjain-456010 Email: raajmedisafe@gmail.com, Website: www.raajmedisafeindia.com Phone: 0734 2518989 2513349 August 27, 2026 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 SCRIP CODE: 524502, ISIN: INE548H01015 Re: NOTICE CONVENING 41ST ANNUAL GENERAL MEETING This is to inform you that 41ST Annual General Meeting of the members of the Company is scheduled to be held on Monday, the 21ST day of September, 2026 at 3.00 P.M. through Video Conferencing/OAVM. Notice convening the said 41ST Annual General Meeting is enclosed herewith. Please be informed that the Annual Report-2025-26 of the Company which also includes the Notice convening the aforesaid meeting has been submitted to BSE vide reference No. 14049578 dated 26.08.2026. Please be informed further that the Annual Report 2025-26 which includes Notice of 41ST Annual General Meeting is also uploaded on the website of the Company www.raajmedisafeindia.com>Investor Relations>Annual Reports. The Company has made necessary arrangements for holding Annual General Meeting through Video Conferencing and e-Voting for resolutions proposed to be transacted at the 41ST AGM for which the Company has made necessary arrangements with Central Depository Services (India) Limited (CDSL) for providing remote evoting facility and e-voting facility to the Shareholders during AGM. Cut off date of evoting : Monday, 14th September, 2026 Commencement of e-voting : 09.00 A.M. on 18th September, 2026 End of e-voting : 05.00 P.M. on 20th September, 2026. Please take the same on record. Thanking you, Yours faithfully, FOR RAAJ MEDISAFE INDIA LIMITED ARPIT BANGUR CHAIRMAN & MANAGING DIRECTOR DIN:02600716 Annual Report : 2025-26 MEDISAFE NOTICE OF 41st ANNUAL GENERAL MEETING Notice is hereby given that 41st Annual General Meeting of the Members of Raaj Medisafe India Limited, will be held on Monday, the 21st day of September, 2026 at 3.00 P.M. through video conferencing/OAVM to transact the following business: - ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026 including Audited Balance Sheet as at March 31, 2026, Statement of Profit & Loss Account and Cash Flow statement for the year ended on that date and the reports of the Board of Directors and Auditors thereon and in this regard, to consider and if thought fit, to pass the following resolutions as Ordinary Resolution: “RESOLVED THAT the audited Financial Statements of the Company for the year ended March 31, 2026 including Audited Balance Sheet as at March 31, 2026, Statement of Profit and Loss account and Cash Flow Statement for the year ended on that date and the reports of the Board of Directors and Auditors thereon laid before this meeting, be and are hereby considered and adopted.” 2. To appoint Shri Arpit Bangur (DIN: 02600716), who retires by rotation, and being eligible offers himself for re-appointment as a Director and in this regard to consider and if thought fit, to pass the following resolutions as Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 of the Companies Act, 2013, Shri Arpit Bangur (DIN: 02600716), who retires by rotation at this meeting and being eligible has offered himself for re-appointment, be and is hereby appointed as a Director of the Company, liable to retire by rotation.” SPECIAL BUSINESS: 3. To consider and if thought fit, to pass the following resolution as Special Resolution: RESOLVED THAT pursuant to the provisions of Regulation 17 (1A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Including any statutory modification(s) or re-enactment (s) thereof for the time being in force), consent of the members of the Company be and is hereby accorded that Smt. Krishna Jajoo (DIN: 02590793) who was appointed as Non-Executive Non-Independent Director in the Board Meeting held on 15.01.2015 (retired by rotation and re-appointed in the Annual General Meeting held on 25.09.2024) to continue to the office of Non-Executive Non-Independent Director who shall be attaining the age of 75 years on March 28, 2027. 4. To consider and if thought fit, to pass the following resolution as Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Regulations 23(4) and any other applicable provisions under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), as amended from time to time, Section 2(76) and other applicable provisions of the Companies Act, 2013 (‘Act’) read with the Rules framed thereunder [including any statutory modification(s) or re-enactment(s) thereof for the time being in force] and other applicable laws / statutory provisions, if any, the Company’s Policy on Related Party Transactions as well as subject to such approval(s) consent(s) and/ or permission(s), as may be required and based on the recommendation of the Audit Committee, consent of the Members of the Company be and is hereby accorded to the Board of Directors of the Company (hereinafter referred to as the ‘Board’, which term shall be deemed to include the Audit Committee or any other Committee constituted / empowered / to be constituted by the Board from time to time to exercise its powers conferred by this Resolution) for the Material Related Party Transaction(s) / Contract(s) / Arrangement(s) / Agreement(s) entered into / proposed to be entered into (whether by way of an individual transaction or transactions taken together or a series of transactions or otherwise), detail as mentioned in the Explanatory Statement annexed herewith, between the Company and Shriji Polymers (India) Limited (“Shriji”) on such terms and conditions as may be mutually agreed between the Company and Shriji, for an aggregate value not exceeding Rs. 1800 Lakhs during FY 2026- 27, provided that such transaction(s) /contract(s)/ arrangement(s) / agreement(s) is/are being carried out at an arm’s length pricing basis and in the ordinary course of business. Annual Report : 2025-26 MEDISAFE RESOLVED FURTHER THAT the Board be and is hereby authorized to do and perform all such acts, deeds, matters and things, as may be necessary, including but not limited to, finalizing the terms and conditions, settling all such issues, questions, difficulties or doubts whatsoever that may arise and to take all such decisions under the powers here in above conferred; and delegate all or any of the powers here in above conferred to any Director, Chief Financial Officer, Company Secretary or any other Officer / Authorised Representative of the Company, without being required to seek further consent from the Members and that the Members shall be deemed to have accorded their consent thereto expressly by the authority of this Resolution. RESOLVED FURTHER THAT all actions taken by the Board in connection with any matter referred to or contemplated in this Resolution, be and are hereby approved, ratified and confirmed in all respect.” 5. To consider and if thought fit, to pass the following resolution as Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Regulations 23(4) and any other applicable provisions under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), as amended from time to time, Section 2(76) and other applicable provisions of the Companies Act, 2013 (‘Act’) read with the Rules framed thereunder [including any statutory modification(s) or re-enactment(s) thereof for the time being in force] and other applicable laws / statutory provisions, if any, the Company’s Policy on Related Party Transactions as well as subject to such approval(s) consent(s) and/ or permission(s), as may be required and based on the reco [Showing first 8,000 characters — download PDF for full document]